Cardiovascular diseases [Internet]. World Health Organisation; Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1.
Olvera Lopez E, Ballard BD, Jan A. Cardiovascular Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Nov 7]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK535419/.
Van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology. 2008;47(1):3–7. https://doi.org/10.1093/rheumatology/kem202.
Hajar R. Risk factors for coronary artery disease: Historical perspectives. Heart Views. 2017;18(3):109. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17.
Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. American Journal of Physiology-Heart and Circulatory Physiology. 2018;315(6):H1569–88. https://doi.org/10.1152/ajpheart.00396.2018.
Appiah D, Nwabuo CC, Ebong IA, Wellons MF, Winters SJ. Trends in Age at Natural Menopause and Reproductive Life Span among US women, 1959–2018. JAMA. 2021;325(13):1328. https://doi.org/10.1001/jama.2021.0278.
Article PubMed PubMed Central Google Scholar
Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. https://doi.org/10.1172/jci.insight.124865.
Pfeifer EC, Crowson CS, Amin S, Gabriel SE, Matteson EL. The Influence of Early Menopause on Cardiovascular Risk in Women with Rheumatoid Arthritis. J Rheumatol. 2014;41(7):1270–5. https://doi.org/10.3899/jrheum.131234.
Chancay MG, Guendsechadze SN, Blanco I. Types of pain and their psychosocial impact in women with rheumatoid arthritis. womens midlife health. 2019;5(1):3. https://doi.org/10.1186/s40695-019-0047-4.
Karvonen-Gutierrez CA, Leis A. Impact of menopause on women with systemic lupus erythematosus. Maturitas. 2021;154:25–30. https://doi.org/10.1016/j.maturitas.2021.09.004.
Rohrich DC, van de Wetering EHM, Rennings AJ, Arts EE, Meek IL, den Broeder AA, et al. Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study. Arthritis Res Ther. 2021;23(1):2. https://doi.org/10.1186/s13075-020-02384-9.
Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176(3):650–8. https://doi.org/10.1111/bjd.15021.
Passia E, Vis M, Coates LC, Soni A, Tchetverikov I, Gerards AH, et al. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther. 2022;24(1):22. https://doi.org/10.1186/s13075-021-02680-y.
Pietrzak A, Czuczwar P, Mosiewicz J, Paszkowski T, Chodorowska G, Bartosinska J, et al. Cardiovascular disease in psoriatic post-menopausal women. Acad Dermatol Venereol. 2015;29(6):1231–4. https://doi.org/10.1111/jdv.12620.
Lauper K, Courvoisier DS, Chevallier P, Finckh A, Gabay C. Incidence and prevalence of major adverse Cardiovascular events in rheumatoid arthritis, psoriatic arthritis, and Axial Spondyloarthritis. Arthritis Care Res. 2018;70(12):1756–63. https://doi.org/10.1002/acr.23567.
Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular Risk in Patients With Psoriasis. Journal of the American College of Cardiology. 2021;77(13):1670–80. https://doi.org/10.1016/j.jacc.2021.02.009.
Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF. NF-κB: An essential transcription factor in psoriasis. Journal of Dermatological Science. 2013;69(2):89–94. https://doi.org/10.1016/j.jdermsci.2012.11.002.
Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. 2021;9(11):1511. https://doi.org/10.3390/biomedicines9111511.
Akkara Veetil BM, Matteson EL, Maradit-Kremers H, McEvoy MT, Crowson CS. Trends in lipid profiles in patients with psoriasis: a population-based analysis. BMC Dermatol. 2012;12(1):20. https://doi.org/10.1186/1471-5945-12-20.
Pietrzak A, Chabros P, Grywalska E, Kiciński P, Franciszkiewicz-Pietrzak K, Krasowska D, et al. Serum lipid metabolism in psoriasis and psoriatic arthritis– an update. aoms. 2019;15(2):369–75. https://doi.org/10.5114/aoms.2018.74021.
Sondermann W, Djeudeu Deudjui DA, Körber A, Slomiany U, Brinker TJ, Erbel R, et al. Psoriasis, cardiovascular risk factors and metabolic disorders: sex-specific findings of a population‐based study. Acad Dermatol Venereol. 2020;34(4):779–86. https://doi.org/10.1111/jdv.16029.
Balci A, Balci D, Yonden Z, Korkmaz I, Yenin JZ, Celik E, et al. Increased amount of visceral Fat in patients with Psoriasis contributes to metabolic syndrome. Dermatology. 2010;220(1):32–7. https://doi.org/10.1159/000254482.
Cesaro A, De Michele G, Fimiani F, Acerbo V, Scherillo G, Signore G, et al. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front Cardiovasc Med. 2023;10:1187735. https://doi.org/10.3389/fcvm.2023.1187735.
Egeberg A, Thyssen J, Jensen P, Gislason G, Skov L. Risk of myocardial infarction in patients with psoriasis and psoriatic arthritis: a Nationwide Cohort Study. Acta Derm Venerol. 2017;97(7):819–24. https://doi.org/10.2340/00015555-2657.
Article CAS PubMed Google Scholar
Parisi R, Rutter MK, Lunt M, Young HS, Symmons DPM, Griffiths CEM, et al. Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink. Journal of Investigative Dermatology. 2015;135(9):2189–97. https://doi.org/10.1038/jid.2015.87.
Tinggaard AB, Hjuler KF, Andersen IT, Winther S, Iversen L, Bøttcher M. Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study. J Intern Med. 2021;290(3):693–703. https://doi.org/10.1111/joim.13311.
Marshall VD, Moustafa F, Hawkins SD, Balkrishnan R, Feldman SR. Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study. Dermatol Ther (Heidelb). 2016;6(4):649–58. https://doi.org/10.1007/s13555-016-0144-3.
Li WQ, Han JL, Manson JE, Rimm EB, Rexrode KM, Curhan GC, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study: nonfatal CVD in women with psoriasis. Br J Dermatol. 2012;166(4):811–8. https://doi.org/10.1111/j.1365-2133.2011.10774.x.
Blegvad C, Andersen A, Adam A, Zachariae C, Skov L. Psoriasis as a Predictor of Cardiometabolic Comorbidity in Women: A Study Based on the Danish National Birth Cohort. Acta Derm Venerol. 2019;99(3):274–8. https://doi.org/10.2340/00015555-3090.
Carvalho AL, Hedrich CM. The Molecular Pathophysiology of Psoriatic Arthritis—The Complex Interplay Between Genetic Predisposition, Epigenetics Factors, and the Microbiome. Front Mol Biosci. 2021;8:662047. https://doi.org/10.3389/fmolb.2021.662047.
Mathieu S, Motreff P, Soubrier M. Spondyloarthropathies: An independent cardiovascular risk factor? Joint Bone Spine. 2010;77(6):542–5. https://doi.org/10.1016/j.jbspin.2010.05.001.
Castañeda S, González-Juanatey C, González-Gay MA. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases. Clinic Rev Allerg Immunol. 2019;56(3):278–92. https://doi.org/10.1007/s12016-017-8635-2.
Bengtsson K, Forsblad-d’Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, et al. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther. 2017;19(1):102. https://doi.org/10.1186/s13075-017-1315-z.
Ogdie A, Yu Y, Haynes K, Love TJ, Maliha S, Jiang Y, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74(2):326–32. https://doi.org/10.1136/annrheumdis-2014-205675.
Polachek A, Touma Z, Anderson M, Eder L. Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies. Arthritis Care & Research. 2017;69(1):67–74. https://doi.org/10.1002/acr.22926.
Liu W, Ma W, Liu H, Li C, Zhang Y, Liu J, et al. Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies. Zhan Y, editor. PLoS ONE. 2021;16(3):e0248564. https://doi.org/10.1371/journal.pone.0248564.
Gazitt T, Pesachov J, Lavi I, Elias M, Haddad A, Feldhamer I, et al. The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study. Arthritis Res Ther. 2022;24(1):16. https://doi.org/10.1186/s13075-021-02703-8.
Degboé Y, Koch R, Zabraniecki L, Jamard B, Couture G, Ruidavets JB, et al. Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study. Front Med. 2022;9:785719. https://doi.org/10.3389/fmed.2022.785719.
Sofogianni A, Stalikas N, Antza C, Tziomalos K. Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine. JPM. 2022;12(7):1180. https://doi.org/10.3390/jpm12071180.
Popescu C, Pintilie AM, Bojinca V, Balanescu A, Ionescu R. Cardiovascular risk in psoriatic arthritis - a cross-sectional study. Maedica (Bucur). 2014;9(1):19–24.
Neerinckx B, Elewaut D, Lories RJ. Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut? Ann Rheum Dis. 2015;74(9):1633–5. https://doi.org/10.1136/annrheumdis-2015-207735.
Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10(10):1461. https://doi.org/10.3390/biom10101461.
Costantino F, Talpin A, Evnouchidou I, Kadi A, Leboime A, Said-Nahal R, et al. ERAP1 Gene Expression Is Influenced by Nonsynonymous Polymorphisms Associated With Predisposition to Spondyloarthritis. Arthritis & Rheumatology. 2015;67(6):1525–34. https://doi.org/10.1002/art.39072.
Zee RYL, Rivera A, Inostroza Y, Ridker PM, Chasman DI, Romero JR. Gene Variation of Endoplasmic Reticulum Aminopeptidases 1 and 2, and Risk of Blood Pressure Progression and Incident Hypertension among 17,255 Initially Healthy Women. International Journal of Genomics. 2018;2018:1–9. https://doi.org/10.1155/2018/2308585.
Fuchs FD, Whelton PK. High Blood Pressure and Cardiovascular Disease. Hypertension. 2020;75(2):285–92. https://doi.org/10.1161/HYPERTENSIONAHA.119.14240.
Almousa S, Alshamaa N, Wannous H, Khder K, Qasem H. Gender-related differences in axial spondyloarthritis (axSpA) patients. The Egyptian Rheumatologist. 2023;45(1):13–6. https://doi.org/10.1016/j.ejr.2022.08.003.
Baniaamam M, Heslinga SC, Boekel L, Konings TC, Handoko ML, Kamp O, et al. The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study. JCM. 2021;10(21):5069. https://doi.org/10.3390/jcm10215069.
Chan SCW, Teo CK, Li PH, Lau KK, Lau CS, Chung HY. Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs. Therapeutic Advances in Musculoskeletal. 2021;13:1759720X2110324. https://doi.org/10.1177/1759720X211032444.
Siao WZ, Liu CH, Wang YH, Wei JCC, Jong GP. Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study. Therapeutic Advances in Musculoskeletal. 2021;13:1759720X2110216. https://doi.org/10.1177/1759720X211021676.
Lin CW, Huang YP, Chiu YH, Ho YT, Pan SL. Increased Risk of Ischemic Stroke in Young Patients with Ankylosing Spondylitis: A Population-Based Longitudinal Follow-Up Study. Rosenbaum JT, editor. PLoS ONE. 2014;9(4):e94027. https://doi.org/10.1371/journal.pone.0094027.
Liew JW, Reveille JD, Castillo M, Sawhney H, Naovarat BS, Heckbert SR, et al. Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study. J Rheumatol. 2021;48(3):361–6. https://doi.org/10.3899/jrheum.200188.
Ferraz-Amaro I, Genre F, Blanco R, Corrales A, Mazón IG, Portilla V, et al. Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients. Seminars in Arthritis and Rheumatism. 2023;60:152198. https://doi.org/10.1016/j.semarthrit.2023.152198.
Menegatti S, Bianchi E, Rogge L. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses. Front Immunol. 2019;10:382. https://doi.org/10.3389/fimmu.2019.00382.
Liew JW, Treu T, Park Y, Ferguson JM, Rosser MA, Ho YL, et al. The association of TNF inhibitor use with incident cardiovascular events in radiographic axial spondyloarthritis. Seminars in Arthritis and Rheumatism. 2024;68:152482. https://doi.org/10.1016/j.semarthrit.2024.152482.
Mease PJ, Bhutani MK, Hass S, Yi E, Hur P, Kim N. Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review. Rheumatol Ther. 2022;9(2):331–78. https://doi.org/10.1007/s40744-021-00407-8.
Eshwar V, Kamath A, Shastry R, Shenoy AK, Kamath P. A Review of the Safety of Interleukin-17A Inhibitor Secukinumab. Pharmaceuticals. 2022;15(11):1365. https://doi.org/10.3390/ph15111365.
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CEM, Papp K, et al. Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials. N Engl J Med. 2014;371(4):326–38. https://doi.org/10.1056/NEJMoa1314258.
Drosos GC, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2022;81(6):768–79. https://doi.org/10.1136/annrheumdis-2021-221733.
Talaulikar V. Menopause transition: Physiology and symptoms. Best Practice & Research Clinical Obstetrics & Gynaecology. 2022;81:3–7. https://doi.org/10.1016/j.bpobgyn.2022.03.003.
Moktan VP, Daoud ND, Tremaine WJ, Loftus EV, Kane SV, Hochwald AP, et al. A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease. Crohns Colitis 360. 2022;4(3). https://doi.org/10.1093/%2Fcrocol%2Fotac027.
Ryczkowska K, Adach W, Janikowski K, Banach M, Bielecka-Dabrowa A. Menopause and women’s cardiovascular health: is it really an obvious relationship? Arch Med Sci. 2023;19(2):458–66. https://doi.org/10.5114/aoms/157308.
Fenton A. Weight, shape, and body composition changes at menopause. J Mid-life Health. 2021;12(3):187. https://doi.org/10.4103/jmh.jmh_123_21.
El Khoudary SR, Shields KJ, Janssen I, Hanley C, Budoff MJ, Barinas-Mitchell E, et al. Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study. The Journal of Clinical Endocrinology & Metabolism. 2015;100(9):3304–12. https://doi.org/10.1210/JC.2015-2110.
Mao L, Wang L, Bennett S, Xu J, Zou J. Effects of follicle-stimulating hormone on fat metabolism and cognitive impairment in women during menopause. Front Physiol. 2022;13:1043237. https://doi.org/10.3389/fphys.2022.1043237.
Sinatora RV, Chagas EFB, Mattera FOP, Mellem LJ, Santos AR de OD, Pereira LP, et al. Relationship of Inflammatory Markers and Metabolic Syndrome in Postmenopausal Women. Metabolites. 2022;12(1):73. https://doi.org/10.3390/metabo12010073.
Abildgaard J, Tingstedt J, Zhao Y, Hartling HJ, Pedersen AT, Lindegaard B, et al. Increased systemic inflammation and altered distribution of T-cell subsets in postmenopausal women. Barreto GE, editor. PLoS ONE. 2020;15(6):e0235174. https://doi.org/10.1371/journal.pone.0235174.
Zhang H, Wang Q, Deng M, Chen Y, Liu W, Huang J, et al. Association between homocysteine, C-reactive protein, lipid level, and sleep quality in perimenopausal and postmenopausal women. Medicine. 2021;100(51):e28408. https://doi.org/10.1097/MD.0000000000028408.
Donovan T, Bain AL, Tu W, Pyne DB, Rao S. Influence of Exercise on Exhausted and Senescent T Cells: A Systematic Review. Front Physiol. 2021;12:668327. https://doi.org/10.3389/fphys.2021.668327.
Fukushima Y, Minato N, Hattori M. The impact of senescence-associated T cells on immunosenescence and age-related disorders. Inflamm Regener. 2018;38(1):24. https://doi.org/10.1186/s41232-018-0082-9.
Choi Y, Chang Y, Kim BK, Kang D, Kwon MJ, Kim CW, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015;80(4):399–405. https://doi.org/10.1016/j.maturitas.2014.12.016.
Jung E, Kong SY, Ro YS, Ryu HH, Shin SD. Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. IJERPH. 2022;19(14):8272. https://doi.org/10.3390/ijerph19148272.
Nurmohamed NS, Gaillard EL, Malkasian S, De Groot RJ, Ibrahim S, Bom MJ, et al. Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation. JAMA Cardiol. 2024;9(9):826. https://doi.org/10.1001/jamacardio.2024.1874.
Gast GCM, Grobbee DE, Pop VJM, Keyzer JJ, Wijnands-van Gent CJM, Samsioe GN, et al. Menopausal Complaints Are Associated With Cardiovascular Risk Factors. Hypertension. 2008;51(6):1492–8. https://doi.org/10.1161/HYPERTENSIONAHA.107.106526.
Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Crandall CJ, Gold EB, Sternfeld B, et al. Vasomotor Symptoms and Lipid Profiles in Women Transitioning Through Menopause: Obstetrics & Gynecology. 2012;119(4):753–61. https://doi.org/10.1097/AOG.0b013e31824a09ec.
Herber-Gast G, Brown W, Mishra G. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study. BJOG. 2015;122(11):1560–7. https://doi.org/10.1111/1471-0528.13163.
Vatankhah H, Khalili P, Vatanparast M, Ayoobi F, Esmaeili-Nadimi A, Jamali Z. Prevalence of early and late menopause and its determinants in Rafsanjan cohort study. Sci Rep. 2023;13(1):1847. https://doi.org/10.1038/s41598-023-28526-y.
Mulvagh SL, Mullen KA, Nerenberg KA, Kirkham AA, Green CR, Dhukai AR, et al. The Canadian women’s Heart Health Alliance Atlas on the epidemiology, diagnosis, and management of Cardiovascular Disease in Women — Chap. 4: sex- and gender-unique disparities: CVD across the Lifespan of a woman. CJC Open. 2022;4(2):115–32. https://doi.org/10.1016/j.cjco.2021.09.013.
Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public Health. 2019;4(11):e553–64. https://doi.org/10.1016/S2468-2667(19)30155-0.
Blake T, Gullick NJ, Hutchinson CE, Barber TM. Psoriatic disease and body composition: A systematic review and narrative synthesis. Nurmohamed M, editor. PLoS ONE. 2020;15(8):e0237598. https://doi.org/10.1371/journal.pone.0237598.
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2021 May 25 [cited 2023 Nov 7];143(21). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000973.
Kottilil S, Mathur P. The influence of inflammation on cardiovascular disease in women. Front Glob Womens Health. 2022;3:979708. https://doi.org/10.3389/fgwh.2022.979708.
Hu S, Lan CCE. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment. IJMS. 2017;18(10):2211. https://doi.org/10.3390/ijms18102211.
Sorriento D, Iaccarino G. Inflammation and Cardiovascular Diseases: The Most Recent Findings. IJMS. 2019;20(16):3879. https://doi.org/10.3390/ijms20163879.
Fiordelisi A, Iaccarino G, Morisco C, Coscioni E, Sorriento D. NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases. IJMS. 2019;20(7):1599. https://doi.org/10.3390/ijms20071599.
Aberra T, Peterson ED, Pagidipati NJ, Mulder H, Wojdyla DM, Philip S, et al. The association between triglycerides and incident cardiovascular disease: What is optimal? Journal of Clinical Lipidology. 2020;14(4):438–447.e3. https://doi.org/10.1016/j.jacl.2020.04.009.
Paiva-Lopes MJ, Delgado Alves J. Psoriasis-associated vascular disease: the role of HDL. J Biomed Sci. 2017;24(1):73. https://doi.org/10.1186/s12929-017-0382-4.
Milan-Mattos JC, Anibal FF, Perseguini NM, Minatel V, Rehder-Santos P, Castro CA, et al. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9):e8392. https://doi.org/10.1590/1414-431x20198392.
留言 (0)